Company intelligence / Profile preview

PharmaNutra USA

Florida, United States
Ownership
Private
Development stage
Other
01

Overview

PharmaNutra USA markets commercially available nutritional supplements and medical devices, including the SiderAL range for iron deficiency, Cetilar range for muscle and joint wellness, and Apportal for immune support. The company leverages its proprietary Sucrosomial Technology, supported by over 150 clinical studies, and serves more than 2 million users worldwide.

Therapeutic areas
HematologyImmunologyMetabolic DisordersRheumatology
Modalities
Nutritional supplementMedical device
Industry
Food & Nutrition
02

Partnerships

Ferrari-AF Corse (Cetilar Racing sponsorship)

Beyond the preview

Go deeper on PharmaNutra USA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaNutra USA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call